Grants per year
Fingerprint
Dive into the research topics where Pedro Antonio Hermida de Viveiros is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 2 Active
-
Prot #CL3-95031-007: A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Ivosidenib in Participants ≥18 Years of Age with Locally Advanced or Metastatic Conventional Chondrosarcoma with an IDH1 Mutation, Untreated or Previously
Hermida de Viveiros, P. A. (PD/PI)
Quintiles, Inc., Servier Bio-Innovation LLC
8/23/24 → 8/23/31
Project: Research project
-
Prot #1403-0019: Brightline-4: A Phase III Open-Label, Single-Arm, Multi-Center Study to Assess the Safety and Efficacy of Brigimadlin (BI 907828) Treatment in Patients with Treatment-Naïve or Pre-Treated Advanced Dedifferentiated Liposarcoma
Hermida de Viveiros, P. A. (PD/PI)
Boehringer Ingelheim Pharmaceuticals, Inc.
1/18/24 → 1/18/27
Project: Research project
-
Utilization of neoadjuvant therapy for localized gastric gastrointestinal stromal tumors and the association with survival
Janczewski, L. M., Vitello, D. J., Warwar, S. C., Buchheit, J. T., Wells, A., Hardy, A., Pollack, S., Viveiros, P., Abad, J., Bentrem, D., Wayne, J. & Chawla, A., Sep 2024, In: Journal of Gastrointestinal Surgery. 28, 9, p. 1512-1518 7 p.Research output: Contribution to journal › Article › peer-review
-
Toll-Like Receptor 4 Agonist Injection with Concurrent Radiotherapy in Patients with Metastatic Soft Tissue Sarcoma: A Phase 1 Nonrandomized Controlled Trial
Seo, Y. D., Lu, H., Black, G., Smythe, K., Yu, Y., Hsu, C., Ng, J., Hermida De Viveiros, P., Warren, E. H., Schroeder, B. A., O'Malley, R. B., Cranmer, L. D., Loggers, E. T., Wagner, M. J., Bonham, L., Pillarisetty, V. G., Kane, G., Berglund, P., Hsu, F. J. & Mi, X. & 7 others, , Dec 21 2023, In: JAMA Oncology. 9, 12, p. 1660-1668 9 p.Research output: Contribution to journal › Article › peer-review
Open Access12 Scopus citations -
A Phase 1/2 Trial Combining Avelumab and Trabectedin for Advanced Liposarcoma and Leiomyosarcoma
Wagner, M. J., Zhang, Y., Cranmer, L. D., Loggers, E. T., Black, G., McDonnell, S., Maxwell, S., Johnson, R., Moore, R., De Viveiros, P. H., Aicher, L., Smythe, K. S., He, Q., Jones, R. L. & Pollack, S. M., Jun 1 2022, In: Clinical Cancer Research. 28, 11, p. 2306-2312 7 p.Research output: Contribution to journal › Article › peer-review
Open Access21 Scopus citations -
Immunologic Gene Signature Analysis Correlates Myeloid Cells and M2 Macrophages with Time to Trabectedin Failure in Sarcoma Patients
Schroeder, B. A., Zhang, Y., Smythe, K. S., Desai, P., Thomas, A., Viveiros, P., Alexiev, B. A., Obeidin, F., Chen, E. Y., Cranmer, L. D., Wagner, M. J., Jones, R. L., Campbell, J. S., Pierce, R. H., He, Q. & Pollack, S. M., Mar 1 2022, In: Cancers. 14, 5, 1290.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Response to Nivolumab and Ipilimumab in Microsatellite Instability-High (MSI-H) Cervical Carcinoma with Acquired Resistance to Pembrolizumab: A Case Report and Literature Review
Gim, G., Kim, Y., Park, Y., Kim, M. J., Nam, M., Yang, W., Duarte, S. E., Jung, C. M., Vagia, E., Viveiros, P. & Chae, Y. K., Jul 1 2022, In: Oncologist. 27, 7, p. 525-531 7 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations
Datasets
-
Exceptional response to chemotherapy followed by concurrent radiotherapy and immunotherapy in a male with primary retroperitoneal serous Adenocarcinoma: a case report and literature review
Chae, Y. K. (Creator), Saleem, N. (Creator), Roh, Y. (Contributor), Bilal, H. (Creator), Viveiros, P. (Creator), Sukhadia, B. (Contributor), Lin, X. (Contributor), Sheikh, M. M. (Creator) & Park, L. C. (Creator), figshare, 2019
DOI: 10.6084/m9.figshare.c.4601576, https://springernature.figshare.com/collections/Exceptional_response_to_chemotherapy_followed_by_concurrent_radiotherapy_and_immunotherapy_in_a_male_with_primary_retroperitoneal_serous_Adenocarcinoma_a_case_report_and_literature_review/4601576
Dataset